METROPOLITAN LIFE INSURANCE CO/NY - RUBIUS THERAPEUTICS INC ownership

RUBIUS THERAPEUTICS INC's ticker is RUBY and the CUSIP is 78116T103. A total of 78 filers reported holding RUBIUS THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.8%.

Quarter-by-quarter ownership
METROPOLITAN LIFE INSURANCE CO/NY ownership history of RUBIUS THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$17,412
-85.4%
3,160
-74.4%
0.00%
-50.0%
Q4 2021$119,635
-47.8%
12,359
-3.7%
0.00%
-33.3%
Q3 2021$229,365
-26.8%
12,8280.0%0.00%
-25.0%
Q2 2021$313,131
+15.8%
12,828
+25.7%
0.00%0.0%
Q1 2021$270,512
+273.4%
10,208
-15.7%
0.00%
+300.0%
Q2 2020$72,442
-28.4%
12,114
+13.7%
0.00%
-50.0%
Q4 2019$101,204
+8.6%
10,653
-10.2%
0.00%0.0%
Q3 2019$93,156
-50.1%
11,8670.0%0.00%
-33.3%
Q2 2019$186,668
-13.1%
11,8670.0%0.00%
-25.0%
Q1 2019$214,793
+85.8%
11,867
+65.0%
0.00%
+100.0%
Q4 2018$115,631
-38.3%
7,191
-7.9%
0.00%
-33.3%
Q3 2018$187,4167,8090.00%
Other shareholders
RUBIUS THERAPEUTICS INC shareholders Q4 2019
NameSharesValueWeighting ↓
Flagship Pioneering Inc. 38,506,526$6,546,1090.21%
HARBOURVEST PARTNERS LLC 986,878$172,7040.06%
Artal Group S.A. 2,042,666$3570.02%
Virtu Financial LLC 68,825$120.00%
ACADIAN ASSET MANAGEMENT LLC 1,277,196$2220.00%
STATE OF MICHIGAN RETIREMENT SYSTEM 640,000$110,1440.00%
Baillie Gifford 4,869,126$837,9770.00%
Citadel Advisors 600$1030.00%
Tower Research Capital LLC (TRC) 25$00.00%
JPMORGAN CHASE & CO 2,196$00.00%
View complete list of RUBIUS THERAPEUTICS INC shareholders